- Home
- TX vs RYTM Comparison
TX vs RYTM Comparison
Compare TX & RYTM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TX
- RYTM
- Stock Information
- Founded
- TX 1961
- RYTM 2008
- Country
- TX Luxembourg
- RYTM United States
- Employees
- TX N/A
- RYTM N/A
- Industry
- TX Steel/Iron Ore
- RYTM Biotechnology: Pharmaceutical Preparations
- Sector
- TX Industrials
- RYTM Health Care
- Exchange
- TX Nasdaq
- RYTM Nasdaq
- Market Cap
- TX 6.2B
- RYTM 6.4B
- IPO Year
- TX 2006
- RYTM 2017
- Fundamental
- Price
- TX $35.37
- RYTM $95.52
- Analyst Decision
- TX Hold
- RYTM Strong Buy
- Analyst Count
- TX 5
- RYTM 13
- Target Price
- TX $34.20
- RYTM $101.92
- AVG Volume (30 Days)
- TX 179.3K
- RYTM 564.2K
- Earning Date
- TX 11-04-2025
- RYTM 11-04-2025
- Dividend Yield
- TX 7.63%
- RYTM N/A
- EPS Growth
- TX N/A
- RYTM N/A
- EPS
- TX 3.03
- RYTM N/A
- Revenue
- TX $16,236,358,000.00
- RYTM $156,287,000.00
- Revenue This Year
- TX N/A
- RYTM $44.69
- Revenue Next Year
- TX $4.84
- RYTM $63.53
- P/E Ratio
- TX $11.48
- RYTM N/A
- Revenue Growth
- TX N/A
- RYTM 53.55
- 52 Week Low
- TX $24.00
- RYTM $45.91
- 52 Week High
- TX $37.98
- RYTM $106.52
- Technical
- Relative Strength Index (RSI)
- TX 53.10
- RYTM 45.59
- Support Level
- TX N/A
- RYTM $94.39
- Resistance Level
- TX $35.14
- RYTM $102.46
- Average True Range (ATR)
- TX 0.76
- RYTM 3.17
- MACD
- TX -1.16
- RYTM -1.49
- Stochastic Oscillator
- TX 99.67
- RYTM 9.27
About TX Ternium S.A. Ternium S.A. (each representing ten shares USD1.00 par value)
Ternium SA is a flat steel producer operating in Mexico, Brazil, Argentina, Colombia, the southern United States, and Central America. It produces finished and semi-finished steel products and iron ore, which are sold either directly to steel manufacturers and steel processors or end-users. The company operates in two segments: Steel and Mining. In its Steel segment, the company produces slabs, billets & round bars, hot-rolled coils & sheets, bars & stirrups, wire rods, steel pipes, and other products. The Mining segment sells iron ore as concentrates (fines) and pellets. The vast majority of its revenue comes from the Steel segment and geographically from Mexico.
About RYTM Rhythm Pharmaceuticals Inc.
Rhythm Pharmaceuticals Inc is a commercial-stage biopharmaceutical company. It is engaged in the development and commercialization of therapies for patients with rare diseases. The company is focused on its melanocortin-4 receptor (MC4R) agonists, including its main asset, IMCIVREE (setmelanotide), as a precision medicine designed to treat hyperphagia and severe obesity caused by rare MC4R pathway diseases. Geographically the company generates its revenue from the United States and internationally with the majority being generated from the United States.